Impact of original, B.1.1.7, and B.1.351/P.1 SARS-CoV-2 lineages on vaccine effectiveness of two doses of COVID-19 mRNA vaccines: Results from a nationwide case-control study in France

BACKGROUND: We aimed to assess the effectiveness of two doses of mRNA COVID-19 vaccines against COVID-19 with the original virus and other lineages circulating in France. METHODS: In this nationwide case-control study, cases were SARS-CoV-2 infected adults with onset of symptoms between 14 February...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Lancet Reg Health Eur
Autori principali: Charmet, Tiffany, Schaeffer, Laura, Grant, Rebecca, Galmiche, Simon, Chény, Olivia, Von Platen, Cassandre, Maurizot, Alexandra, Rogoff, Alexandra, Omar, Faïza, David, Christophe, Septfons, Alexandra, Cauchemez, Simon, Gaymard, Alexandre, Lina, Bruno, Lefrancois, Louise H, Enouf, Vincent, van der Werf, Sylvie, Mailles, Alexandra, Levy-Bruhl, Daniel, Carrat, Fabrice, Fontanet, Arnaud
Natura: Artigo
Lingua:Inglês
Pubblicazione: Elsevier 2021
Soggetti:
Research Paper
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC8277121/
https://ncbi.nlm.nih.gov/pubmed/34278372
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.lanepe.2021.100171
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi